Backbone categories | N = 577 n (%)1 | Unadjusted average total cost per patient (US dollars) |
Irinotecan + EGFR | 159 (27.56) | 13,869.89 |
Anti-EGFR-monotherapy | 121 (20.97) | 13,501.02 |
Irinotecan-based (without EGFR) | 82 (14.21) | 9345.34 |
Capecitabine-based (without EGFR) | 61 (10.57) | 5419.77 |
Oxaliplatin-based (without EGFR) | 58 (10.05) | 16,464.73 |
Multi-drug (without EGFR) | 43 (7.45) | 8989.48 |
Others | 34 (5.89) | 10,327.48 |
Capecitabine + EGFR | 7 (1.21) | 10,261.96 |
Multi-drug + EGFR | 6 (1.04) | 20,209.34 |
Oxaliplatin + EGFR | 6 (1.04) | 17,116.68 |